Search results
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters· 6 days ago, opens new tab Trodelvy failed to improve survival for patients with advanced bladder cancer and...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 2 days agoRNAi Therapeutics and Technology Market Worth USD 5.36 Billion by 2031 at 16.6% CAGR- Exclusive Report by InsightAce Analytic Pvt. Ltd. PR Newswire JERSEY CITY, N.J., June 4, 2024 JERSEY CITY, N.J., June 4, 2024 /PRNewswire/ -- InsightAce Analytic
The Most Profitable Biotechnology Company in the World
Insider Monkey via Yahoo Finance· 6 days agoIn this article, we will be taking a look at the most profitable biotechnology company in the world. If you want to learn about more, head straight to the 15 Most Profitable Biotechnology Companies ...
Former GE General Counsel Joins Paul Weiss As Partner
LawFuel· 1 day agoPaul, Weiss, Rifkind, Wharton & Garrison LLP announced today that Michael Holston will join the firm...
Stocks of Local Interest
Clinton Herald, Iowa· 2 days agoJun. 3—Closing prices Monday: Adv Auto Parts 67.42 Abbott Labs 102.87 ADM 61.99 Ameriprise 431.04 AutoZone, Inc. 2,772.62 Boeing 184.57 Bank of America 39.88 BP PLC ADR 36.40 ConAgra Foods 29.73 ...
Medicenna To Present Evidence of Durable Single Agent Activity and Potent Immune Effector Response...
Benzinga· 6 days agoMDNA11 demonstrates durable response in pancreatic cancer patient with 100% regression of target and non-target lesions for over 104 weeks and continues to show remission 4 months after stopping treatment Melanoma
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
Zacks· 3 days agoFree Report) , a passively managed exchange traded fund launched on 06/23/2005. While an excellent vehicle for long term investors, passively managed ETFs are a popular choice among institutional ...